Is Intramuscular or Smoked Cannabis the Future of Managing Pain?

Article by Karhlyle Fletcher, The Fresh Toast via Growth Op

World NewsWellnessMedicalLegalizationHealth Is intramuscular or smoked weed the future of managing pain? The available data seems to suggest that alternative methods to traditional oral consumption methods may be more effective at treating pain. Author of the article:Karhlyle Fletcher • The Fresh Toast December 2020 meta-analysis comprehensively reviewed available medical literature on cannabinoids and acute pain. / PHOTO BY ISTOCK / GETTY IMAGES PLUS

Some suggest happiness is all about increasing pleasure and limiting pain. As such, pain is a pressing issue in many people’s lives. Whether that pain is chronic or acute, it can be debilitating. And because of that, at least in part, millions of people in the U.S. and elsewhere find themselves relying on opiates.

Still, research is pointing towards some alternatives. Following up on 2018 research that found cannabinoids may up a patient’s pain threshold while alos making pain seem less unpleasant, a December 2020 meta-analysis comprehensively reviewed available medical literature on cannabinoids and acute pain.

Differences in administration count

After searching the available data, the analysis selected six studies: two from the U.S., two out of Canada, one from the U.K. and one that featured contributions from Germany, Italy and the U.K. Five of them studied orally administered cannabinoids, while one explored the effects of intramuscular cannabinoids.

Throughout the research, the group given orally administered cannabinoids did not differ significantly from the controls, who were provided a placebo, but the intramuscular patients saw a significant improvement in acute pain.

The analysis went on to posit that this may be the result of differences in the metabolization of cannabinoids administered in various ways. “Specifically, oral absorption of cannabinoids is slow and variable with maximal plasma concentrations occurring 60 to 120 minutes post-ingestion, but can be delayed upward of six hours,” the study noted.

“Cannabinoids are subjective to significant first-pass liver metabolism, which further reduces the bioavailability. Utilizing transdermal, inhaled or oral transmucosal formulations allows for direct plasma uptake and avoidance of the first-pass effect. Inhaled cannabinoids reach peak effect in 10 min and plasma levels are maintained for several hours,” study authors pointed out.

Here, the available data seems to suggest that alternative methods to traditional oral consumption methods may be more effective at treating pain. Water-soluble oral administered cannabis may also be an adequate alternative as it also has a faster activation time.

Read the full article here.

About Dankr NewsBot

Beep Boop. I'm just a bot who brings you the dankest news in the biz

Leave a Reply

Powered by Dragonballsuper Youtube Download animeshow